Business Description
ADR Biomedical Holdings Inc
ISIN : JP3426500009
Total Employee Number:
11Description
ADR Biomedical Holdings Inc is engaged in research and development in overcoming diseases for which there are currently no effective treatments, using adipose tissue-derived regenerative (stem) cells (ADRCs) obtained from human adipose tissue using its proprietary Cellution device. Its technology includes Adipose tissue-derived regenerative (stem) cells, Superiority of ADR Biomedical Holdings Technology, and Paper.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.52 | |||||
Equity-to-Asset | 0.06 | |||||
Debt-to-Equity | 2.27 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1.71 | |||||
Beneish M-Score | 65.07 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -71.2 | |||||
3-Year EBITDA Growth Rate | 18.7 | |||||
3-Year EPS without NRI Growth Rate | -8.5 | |||||
3-Year FCF Growth Rate | -58.3 | |||||
3-Year Book Growth Rate | -79.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.83 | |||||
9-Day RSI | 54.79 | |||||
14-Day RSI | 53.24 | |||||
3-1 Month Momentum % | -4.79 | |||||
6-1 Month Momentum % | -7.67 | |||||
12-1 Month Momentum % | -11.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.55 | |||||
Quick Ratio | 1.25 | |||||
Cash Ratio | 0.56 | |||||
Days Inventory | 546.93 | |||||
Days Sales Outstanding | 38.3 | |||||
Days Payable | 8.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 33.83 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 20.71 | |||||
Operating Margin % | -1777.23 | |||||
Net Margin % | -778.43 | |||||
EBITDA Margin % | -742.68 | |||||
FCF Margin % | -1539.13 | |||||
OCF Margin % | -1539.13 | |||||
ROE % | -126.61 | |||||
ROA % | -26.4 | |||||
ROIC % | -71.74 | |||||
3-Year ROIIC % | 1.32 | |||||
ROC (Joel Greenblatt) % | -15.3 | |||||
ROCE % | -31.67 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 140.96 | |||||
PB Ratio | 326.31 | |||||
Price-to-Tangible-Book | 325.91 | |||||
EV-to-EBIT | -18.61 | |||||
EV-to-EBITDA | -18.64 | |||||
EV-to-Revenue | 138.49 | |||||
EV-to-FCF | -9.11 | |||||
Price-to-GF-Value | 19.92 | |||||
Price-to-Median-PS-Value | 26.97 | |||||
| Price-to-Net-Current-Asset-Value | 1610 | |||||
Earnings Yield (Greenblatt) % | -5.38 | |||||
FCF Yield % | -10.92 | |||||
Forward Rate of Return (Yacktman) % | -50.37 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ADR Biomedical Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 50.988 | ||
| EPS (TTM) (円) | -44.46 | ||
| Beta | 0.0937 | ||
| 3-Year Sharpe Ratio | -0.3 | ||
| 3-Year Sortino Ratio | -0.42 | ||
| Volatility % | 18.25 | ||
| 14-Day RSI | 53.24 | ||
| 14-Day ATR (円) | 16.300059 | ||
| 20-Day SMA (円) | 791.5 | ||
| 12-1 Month Momentum % | -11.47 | ||
| 52-Week Range (円) | 769 - 950 | ||
| Shares Outstanding (Mil) | 8.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ADR Biomedical Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ADR Biomedical Holdings Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| 5:1 Stock Split | 2018-01-29 | 481.60 (-1.91%) | ||
| 0.01:1 Stock Split | 2013-09-26 | 400.00 (+5.26%) |
Show
Entries
ADR Biomedical Holdings Inc Frequently Asked Questions
What is ADR Biomedical Holdings Inc(TSE:3750)'s stock price today?
The current price of TSE:3750 is 円805.00. The 52 week high of TSE:3750 is 円950.00 and 52 week low is 円769.00.
When is next earnings date of ADR Biomedical Holdings Inc(TSE:3750)?
The next earnings date of ADR Biomedical Holdings Inc(TSE:3750) is .
Does ADR Biomedical Holdings Inc(TSE:3750) pay dividends? If so, how much?
ADR Biomedical Holdings Inc(TSE:3750) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on ADR Biomedical Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers